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Autophagy is a cellular catabolic mechanism that
plays an essential function in protecting multicellular
eukaryotes from neurodegeneration, cancer, and
other diseases. However, we still know very little
about mechanisms regulating autophagy under
normal homeostatic conditions when nutrients are
not limiting. In a genome-wide human siRNA screen,
we demonstrate that under normal nutrient condi-
tions upregulation of autophagy requires the type III
PI3 kinase, but not inhibition of mTORC1, the essen-
tial negative regulator of starvation-induced autoph-
agy. We show that a group of growth factors and
cytokines inhibit the type III PI3 kinase through
multiple pathways, including the MAPK-ERK1/2,
Stat3, Akt/Foxo3, and CXCR4/GPCR, which are all
known to positively regulate cell growth and prolifer-
ation. Our study suggests that the type III PI3 kinase
integrates diverse signals to regulate cellular levels
of autophagy, and that autophagy and cell prolifera-
tion may represent two alternative cell fates that are
regulated in a mutually exclusive manner.
INTRODUCTION
Autophagy is an evolutionarily conserved catabolic process
mediating turnover of intracellular constituents in a lysosome-
dependent manner (Levine and Klionsky, 2004). In unicellular
eukaryotes autophagy serves as a survival mechanism during
periods of starvation by promoting intracellular recycling (Levine
and Klionsky, 2004; Levine and Kroemer, 2008). In metazoa
autophagy functions as an important intracellular catabolic
mechanism involved in cellular homeostasis during development
and adult life, by mediating the turnover of malfunctioning, aged,
or damaged proteins and organelles (Levine and Kroemer, 2008).
Autophagy can also be activated in response to many forms
of cellular stress beyond nutrient starvation, including DNA
damage, endoplasmic reticulum (ER) stress, reactive oxygenDevelopmspecies, and on invasion by intracellular pathogens. On the
organismal level, autophagy has been shown to participate in
both innate and acquired immunity (Schmid and Munz, 2007),
tumor suppression (Liang et al., 1999; Mathew et al., 2007a;
Mathew et al., 2007b), and protection from neurodegeneration
(Hara et al., 2006; Komatsu et al., 2006).
The signaling mechanisms leading to the activation of autoph-
agy under nutrient starvation conditions have been extensively
characterized. Inactivation of the mTORC1 kinase, a down-
stream effector of the type I PI3 kinase/Akt signaling, is critical
for the activation of autophagy under these conditions (Levine
and Klionsky, 2004; Levine and Kroemer, 2008). However, cells
in complex multicellular eukaryotes such as mammals rarely
experience nutrient deprivation under physiological conditions.
Nevertheless, autophagy plays an essential role in maintenance
of normal homeostasis at both cellular and organismal levels, as
well as can be induced by a variety of cellular stresses under
conditions when mTORC1 is known or expected to be active
(Sakaki et al., 2008). Thus, there is an urgent need to understand
the mechanisms that regulate autophagy under normal nutri-
tional conditions.
To address this question and to understand the global regula-
tion of mammalian autophagy, we carried out a genome-wide
image-based siRNA screen for genes involved in the regulation
of autophagy under normal nutrient conditions. Additionally we
developed and executed a series of high-throughput character-
ization assays and screens allowing us to characterize the hit
genes and further the understanding of the global regulation of
mammalian autophagy. Our data indicate that under normal
nutrition autophagy is regulated by a wide array of extracellular
factors, including growth factors, cytokines, and chemokines.
This response is mediated by a variety of cell surface receptor
signaling pathways and, unlike during starvation, can be regu-
lated in mTORC1 independent manner.RESULTS
Genome-Wide siRNA Screen for Genes Regulating
Autophagy
To identify new genes involved in the regulation of autophagy in
mammals we screened a human genomic library containingental Cell 18, 1041–1052, June 15, 2010 ª2010 Elsevier Inc. 1041
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Figure 1. High-Throughput Image-Based
Screen for Genes Regulating Autophagy
(A) H4 cells stably expressing LC3-GFP were
transfected with nontargeting siRNA (ntRNA) or
siRNA against mTOR or Atg5 for 72 hr, fixed, coun-
terstained with Hoechst, and imaged on a high-
throughput fluorescent microscope (103). The
bottom panels show results of image segmenta-
tion used for quantification of the ratio of soluble
(diffuse cytosolic) versus autophagosome-associ-
ated (punctate) LC3-GFP: blue, nuclei; green, cell
segmentation; pink, autophagosomal LC3-GFP.
(B) Quantification of data from (A).
(C) Confirmation of knockdown of selected screen
hits by RT-PCR. H4 cells were transfected with
indicated siRNAs for 72 hr.
(D) Confirmation of changes in levels of autophagy
after knockdown of FGFR1, Stat3, or CLCF1 by
western blot with antibodies against LC3. E64d
(10 mg/mL) was added to the media for 8 hr before
cells were harvested. Quantification of LC3 II/
tubulin ratio is shown.
(E and F) Exogenous CLCF1 can suppress
increase in autophagy induced by knockdown of
CLCF1. H4 (E) or H4 LC3-GFP (F) cells were trans-
fected with nontargeting siRNA (nt) or siRNA
against CLCF1 and grown in the absence or pres-
ence of 100 ng/mL human CLCF1. Levels of
autophagy were assessed by western blot (E) or
by quantification of autophagosomal LC3-GFP
(F). All error bars are SEM. *p = 0.05 based on
two-tailed Student’s t test (nR 10).
Developmental Cell
mTORC1 Independent Regulation of AutophagysiRNA pools targeting 21,121 genes, with four independent
siRNA oligonucleotides for each gene. To quantify levels of
autophagy, we used human neuroblastoma H4 cells stably
expressing the LC3-GFP reporter (Shibata et al., 2006). In this
system, transfection of siRNA targeting the essential autophagy
mediator ATG5 led to significant downregulation of autophagy,
as assessed by a reduction in the number and intensity of LC3-
GFP positive autophagosomes (Figures 1A and 1B) as well as
a decrease in endogenous LC3II levels on a western blot (see
Figure S1A available online) (Klionsky et al., 2008). Conversely,
transfection of siRNA targeting subunits of mTORC1, mTOR or
Raptor, led to increased levels of autophagy (Figures 1A and
1B; Figures S1B and S1C). The primary screen resulted in the
identification of 574 genes (2.7%) that knockdown led to a signif-
icant (p < 0.02) decrease or increase in LC3-GFP positive auto-
phagosome formation. The candidate geneswere then confirmed
in a secondary screen in which the four pool siRNAs targeting
different regions of the same gene, were evaluated separately.
A total of 236 of the candidate genes (41%) were confirmed1042 Developmental Cell 18, 1041–1052, June 15, 2010 ª2010 Elsevier Inc.with at least two independent siRNA
oligonucleotides resulting in significant
increase or decrease in the levels of
autophagy as compared to nontargeting
siRNA controls (Figure 2A and Table 1;
Table S1) (p < 0.01). The hit genes included
21 (9%) genes known to be involved or
implicated in the regulation of autophagy,
including ATG5, ATG7, IGF1, Rab7, andcalpain-1 (Table S2). The ability to identify theseknown autophagy
genes provides an important validation of our screening method.
As further validation of our hits, we confirmed knockdown of
a selected group by RT-PCR and verified their ability to induce
autophagy by western blot (Figures 1C and 1D). Importantly,
stimulation of autophagy by knockdown of the cardiotrophin-
like cytokine factor 1 (CLCF1), one of the cytokines identified in
the screen, was suppressed in the presence of exogenous
human CLCF1, demonstrating specificity of the observed
phenotype (Figures 1E and 1F).
Although our screen was conducted under normal nutritional
conditions when levels of autophagy are low, we were able to
uncover a small set of hits (17. 7% of all confirmed genes) that
resulted in the suppression of autophagy. Consistent with the
function of these genes in mediation of autophagy, knockdown
of a large fraction (35%) of these genes was able to downregu-
late autophagy in the presence of rapamycin, a potent mTORC1
inhibitor and well-known inducer of autophagy (Figure 2A; Table
S3) (Klionsky et al., 2008; Levine and Kroemer, 2008).
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Figure 2. High-Throughput Characteriza-
tion of the Autophagy Screen Hits
(A) Summary of all screen and characterization
assays and their results.
(B) Quantification of levels of autophagy in H3 LC3-
GFP cells transfected with nontargeting siRNA or
siRNA against mTOR or COPB2. Lysosomal
(10 mg/mL) protease inhibitor E64d was added
for 8 hr before fixation. p(mTOR) = 6.5 3 10
17.
(C) Quantification of ER stress in H4 cells treated
with indicated levels of tumicamycin (Tm) for
24 hr by in-cell western assay with antibody
against GRP78 and GRP94.
(D) Quantification of mTORC1 activity by in-cell
western assay with antibody against phospho-
rpS6 (Ser235/236) in H4 cells transfected with non-
targeting siRNA or siRNA against mTOR for 72 hr.
(E) To assess the type III PI3 kinase activity, H4
cells stably expressing the PtdIns3P reporter
FYVE-dsRed were transfected with siRNA against
mTOR or Vps34. Right-hand panels represent the
results of image segmentation used for quantifica-
tion of the ratio of soluble (diffuse cytosolic) versus
vesicle-associated (punctate) FYVE-dsRed: blue,
nuclei; green, cell segmentation; pink, vesicular
FYVE-dsRed.
(F) Quantification of data from (E). All error bars are
SEM (nR 6).
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Because knockdown of the vast majority of hits (219, 93% of all
confirmed) led to the induction of autophagy, our subsequent
analyses concentrated on this group of genes. To elucidate the
molecular pathways involved in regulation of autophagy by the
candidate genes, we developed and carried out a series of addi-
tional high-throughput assays and screens to characterize the
hits (Figure 2A). Accumulation of autophagosomal LC3-GFP
can be due to either increased initiation of autophagy or to
a block in degradation of autophagosomes. To distinguish
between these possibilities, we evaluated induction of autoph-
agy in the presence of the inhibitor of lysosomal proteases
E64d. As expected, treatment with E64d led to a significant
increase in levels of autophagy after knockdown of mTOR, but
did not affect levels of autophagy induced by knockdown of
the coatamer subunit COPB2, which is predicted to inhibit
general vesicular trafficking (Figure 2B). Knockdown of 143
genes (69% of 206 tested) led to significantly higher induction
of autophagy in the presence than in the absence of E64d
(Table 1; Table S1), suggesting that similarly to starvation or inhi-
bition of mTORC1, loss of these genes results in enhanced initi-
ation of autophagy. On the other hand, the 63 (31%) genes that
knockdown was unable to induce autophagy in the presence of
E64d, likely cause the accumulation of autophagosomal LC3-
GFP by blocking maturation and/or degradation of autophago-
somes. For 24 of those genes, this may be due to a general
defect in lysosomal proteolysis as induction of autophagy on
loss of these genes was accompanied by significant expansion
of the lysosomal compartment, as assessed by the accumula-Developmtion of lysosomal reporter protein Lamp1-RFP (Figures S2A
and S2B and Table S4).
Autophagy is often induced in response to various forms of
cellular stress, including ER stress (Ogata et al., 2006; Yorimitsu
et al., 2006). In our screen we observed that the accumulation of
LC3-GFP was sometimes associated with decreased cell
viability (Table S1), raising the question as to whether these
cases may reflect a general response to cellular stress rather
than a specific function in the regulation of autophagy. To assess
that, we carried out an in-cell-western assay to measure the
expression levels of GRP78 and GRP94, specific markers of
ER stress. As expected, treatment with the inducer of ER stress,
tunicamycin, led to a dose-dependent upregulation of GRP78
and GRP94 (Figure 2C), as well as an increase in autophagy
(data not shown). However, with just a few exceptions (6 of
188 genes tested, 3%) (Table S5), we were unable to detect
significant upregulation of ER stress after knockdown of the hit
genes. Therefore, ER stress does not seem to be a major contrib-
utor to the induction of autophagy observed in our screen.
We evaluated the contribution of mTORC1, an essential
suppressor of starvation-induced autophagy (Levine and Klion-
sky, 2004), by an in-cell-western assay of the phosphorylation
status of a downstream target of mTORC1 signaling, the ribo-
somal protein S6 (rpS6) (Hoffman et al., 2010). As expected,
transfection of siRNA against mTOR led to a significant decrease
in the levels of rpS6 phosphorylation as compared to nontarget-
ing siRNA (Figure 2D). Surprisingly, induction of autophagy was
strongly correlated with downregulation of mTORC1 activity for
only 14 (6%) of the 219 confirmed genes (Figure 2A; Table S1).ental Cell 18, 1041–1052, June 15, 2010 ª2010 Elsevier Inc. 1043
Table 1. Genes Regulating and Mediating Autophagy Identified in the Screen
Gene Symbol Gene ID Gene Symbol Gene ID Gene Symbol Gene ID Gene Symbol Gene ID
Genes in which knockdown increases autophagy flux
ADMR 11318 FANCC 2176 MMP17 4326 SCOTIN 51246
ADRA1A 148 FBXL20 84961 MUC3A 4584 SDHB 6390
AGER 177 FGFR1 2260 MYL3 4634 SEMA4B 10509
ARSE 415 FRAG1 27315 NAGK 55577 SETDB1 9869
ATG16L2 89849 GABBR2 9568 NCR3 259197 SF3A2 8175
AURKA 6790 GHSR 2693 NFIL3 4783 SIDT1 54847
BAI3 577 GJA4 2701 NNMT 4837 SIX2 10736
BAIAP2 10458 GNAI1 2770 NPTX1 4884 SLC25A19 60386
C18orf8 29919 GNG11 2791 NUDT1 4521 SMARCD1 6602
CAMKV 79012 GNG5 2787 OGDH 4967 SOD1 6647
CAPN1 823 GNRH2 2797 P2RX1 5023 SORCS2 57537
CARKL 23729 GPX2 2877 PA2G4 5036 SP140 11262
CASP1 834 GRK6 2870 PAK6 56924 STAT3 6774
CDCA8 55143 GTF2IRD2 84163 PAQR6 79957 TACR2 6865
CDK5RAP3 80279 GTPBP4 23560 PCGF1 84759 TGFBI 7045
CDKN2D 1032 HIST2H3C 126961 PDCD5 9141 THBS2 7058
CEND1 51286 HIVEP2 3097 PFDN2 5202 TINP1 10412
CENPJ 55835 HLA-DRB1 3123 PFKL 5211 TLR3 7098
CHAF1B 8208 HMGCL 3155 PHB2 11331 TMPRSS5 80975
CHID1 66005 HRC 3270 PIGY 84992 TNF 7124
CHRND 1144 HSFY2 159119 PLDN 26258 TNFRSF17 608
CLCF1 23529 ICT1 3396 PLXNA2 5362 TRIM69 140691
CNKSR2 22866 IGF1 3479 POLR3G 10622 TRNT1 51095
COL14A1 7373 IRAK3 11213 PPFIA4 8497 TRPA1 8989
COPE 11316 ITGAV 3685 PRAF2 11230 TSPAN4 7106
COX5A 9377 KIAA0133 9816 PRKAG3 53632 TUBGCP6 85378
CPNE6 9362 KIAA0196 9897 PRKCZ 5590 UBE1L2 55236
CXCL12 6387 KRT18 3875 PROSC 11212 UBE2D1 7321
CYP27A1 1593 LIF 3976 PSD 5662 UNC13B 10497
DBX1 120237 LOC285643 285643 PTGER2 5732 USP19 10869
DDX24 57062 LOC388959 388959 PTMA 5757 USP24 23358
EP300 2033 MAP3K7IP1 10454 PTPRH 5794 WASF1 8936
EPHA6 203806 MATN3 4148 PTPRU 10076 WFDC2 10406
EVL 51466 MCCC1 56922 RBBP8 5932 XPO1 7514
F12 2161 MMACHC 25974 RFX1 5989 ZFY 7544
FABP1 2168 MMP10 4319 SCAMP4 113178
Genes in which knockdown increases autophagy due to decreased lysosomal processing
ADM 133 DOCK8 81704 NTN2L 4917 SORBS3 10174
AMH 268 EGLN2 112398 NUPR1 26471 SSPN 8082
ARCN1 372 ERH 2079 NUTF2 10204 SUV39H1 6839
ASMT 438 FCER1A 2205 PLAGL2 5326 TAF2 6873
BGN 633 FXYD2 486 PLCH2 9651 TH 7054
C11orf68 83638 GJA3 2700 PNKD 25953 TNFRSF19L 84957
C2orf13 200558 HMBS 3145 PPARD 5467 TOM1 10043
C5AR1 728 HNRPK 3190 PRKAA2 5563 TRAF1 7185
CCT4 10575 HNRPM 4670 PRKCA 5578 TRHR 7201
CD300C 10871 HNRPU 3192 PTCRA 171558 TRIM8 81603
CD79A 973 HOXD11 3237 QSCN6 5768 TRIP6 7205
CENPE 1062 IHPK3 117283 RAB7A 7879 TUBB2A 7280
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Table 1. Continued
Gene Symbol Gene ID Gene Symbol Gene ID Gene Symbol Gene ID Gene Symbol Gene ID
CHKA 1119 INTS4 92105 RAGE 5891 USP54 159195
CKAP5 9793 MKLN1 4289 RANGAP1 5905 UTS2R 2837
CLCN1 1180 NAT9 26151 RELN 5649 ZBTB16 7704
COPB2 9276 NLK 51701 RORC 6097
Genes in which knockdown increases autophagy (flux not determined)
BPGM 669 KIF11 3832 NPTN 27020 TRPM3 80036
FGF2 2247 LOR 4014 RIPK1 8737
GCM2 9247 OA48-18 10414 RNPEPL1 57140
GFER 2671 NOXO1 124056 TACC2 10579
Genes in which knockdown decreases autophagy
ATG5 9474 KIF5C 3800 PDCL 5082 TCEB3 6924
ATG7 10533 LOC285647 285647 PGGT1B 5229 TPR 7175
CATSPER4 378807 MBP 4155 RELA 5970
GAB1 2549 MEGF10 84466 SMYD3 64754
GPR18 2841 NFKB1 4790 STIM1 6786
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able to enhance initiation of autophagy based on the E64d data,
only 7 (5%) led to the suppression of mTORC1 activity, suggest-
ing that only this small subset may be involved in the regulation of
mTORC1. Conversely, knockdown of four of these genes (3%)
led to both upregulation of autophagy and of mTORC1 activity
(Table S1). Therefore, high mTORC1 activity may not be always
incompatible with the induction of autophagy. The fact that
knockdown of the vast majority of the screen hits did not affect
mTORC1 activity suggests that these genes act either down-
stream or independently of this kinase. Because our hits include
a large group of known upstream regulators of cellular signaling
such as cytokines, growth factors, and their receptors (see
Bioinformatics Analysis for details), our data implicate the exis-
tence of mTORC1 independent pathways regulating initiation
of autophagy under normal nutritional conditions.
To characterize the contribution of the type III PI3 kinase, an
important mediator of autophagy that regulation remains poorly
understood (Levine and Klionsky, 2004), we used H4 cells stably
expressing FYVE-dsRed reporter, which specifically binds to its
product, PtdIns3P. Confirming the major role of the type III PI3
kinase in regulation of PtdIns3P levels in our system, transfection
of siRNA against the catalytic component of this kinase, Vps34,
led to a significant decline in FYVE-dsRed vesicle recruitment
(Figures 2E and 2F). The relationship between mTORC1 and
the type III PI3 kinase remains poorly understood. Although in
some contexts Vps34 can play a positive role in the mediation
of mTORC1 activation in response to amino acid stimulation
(Byfield et al., 2005; Nobukuni et al., 2005), we did not observe
significant downregulation of mTORC1 activity after knockdown
of Vps34 (Figure S2C and S2D). On the other hand, Vps34 is
known to function downstream of TORC1 during induction of
autophagy in Drosophila (Juhasz et al., 2008), and inhibition of
mTORC1 due to either starvation or rapamycin treatment
of mammalian cells can lead to accumulation of vesicle associ-
ated PtdIns3P (Takahashi et al., 2007; Tassa et al., 2003; Zhang
et al., 2007). Consistent with the data placing Vps34 downstreamDevelopmof mTORC1 in the regulation of autophagy, in our system knock-
down of either mTOR or Raptor increased FYVE-dsRed vesicle
recruitment (Figure 2E and 2F; Figure S2E). Using this system
we determined that knockdown of 110 (47%) of the 236
confirmed genes led to a significant (p < 0.05) alteration in
PtdIns3P levels, which correlated positively with the change in
autophagosome formation (Table S1), suggesting that these
genes act upstream of the type III PI3 kinase in the regulation
of autophagy. These data confirm that the type III PI3 kinase
plays an essential function in the regulation of autophagy under
normal nutritional conditions and provide new insights into the
mechanisms that regulate cellular levels of PtdIns3P.
Extracellular Factors Regulate Autophagy under Normal
Nutrition
To gain further insight into the mechanisms by which the
identified genes regulate cellular levels of autophagy, we used
bioinformatics analysis. Molecular function analysis of the 236
confirmed hits using Gene Ontology (GO) showed a highly signif-
icant enrichment in kinases (p = 0.0006), proteins with receptor
activity (p = 7.7 3 105) and extracellular matrix proteins (p =
0.03) (Figure 3A; Table S6). The latter categories suggest that
extracellular environment including the presence of growth
factors, hormones and cytokines, as well as extracellular matrix
and cell-cell contacts, may play especially important function in
the regulation of autophagy under normal nutritional conditions.
The results of GO biological process analysis also showed signif-
icant enrichment in signaling molecules (p = 2.8 3 107)
(Figure 3B; Table S7). In agreement with the function of extracel-
lular clues in regulation of autophagy, further subdivision of these
molecules revealed that the largest subgroup (49%) is involved in
cell surface receptor signal transduction.
Cytokines Regulate Autophagy Independently
of mTORC1
As an siRNA independent confirmation of the function of extra-
cellular molecules in the regulation of autophagy, we treatedental Cell 18, 1041–1052, June 15, 2010 ª2010 Elsevier Inc. 1045
Figure 3. Autophagy Is Regulated in Response to Extracellular Stimuli through Multiple Receptor-Mediated Signaling Pathways
(A and B) Classification of the autophagy screen hits into molecular function (A) and biological process (B) categories according to the PANTHER system. In (B),
subdivisions of the biological process ‘‘Signal Transduction’’ category are included. Categories with at least five genes are displayed. Categories with p < 0.05
(hypergeometric distribution) are considered enriched.
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as hits in our screen. Based on the results of the characterization
assays, knockdown of IGF1, FGF2, LIF, CLCF1, and the chemo-
kine SDF1 (CXCL12) resulted in mTORC1 independent increase
in initiation of autophagy (Table S1). In agreement, treatment of
H4 LC3-GFP cells grown in a serum-free medium with any of
these cytokines led to a significant downregulation of autophagy
as measured by LC3-GFP translocation (Figure 4A; Figure S3A).
This data were furthermore confirmed in multiple cell lines (H4,
HEK293, HeLa, and MCF7) by western blot (Figures 4B–4F;
Figures S3B–S3L; data not shown). In agreement with the
proposed function of cytokines in the regulation of autophagy,
cells cultured in their absence displayed high basal levels of
autophagy as assessed by accumulation of LC3II, which was
suppressed partially by the addition of even single cytokines
identified in the screen. Thus, we have identified a group of cyto-
kines and growth factors that are both necessary and sufficient
for the regulation of autophagy.
To determine whether downregulation of autophagy by
these cytokines is due to reactivation of mTORC1 signaling,
we inhibited mTORC1 by addition of rapamycin. As expected,
treatment with rapamycin led to increases in the overall levels
of autophagy (Figure 4). Despite efficient inhibition of mTORC1
as evidenced by dephosphorylation of both rpS6 and the S6
kinase, treatment with IGF1, FGF2, LIF, CLCF1, or SDF1 was
able to reduce autophagy induced by rapamycin (Figures 4B–1046 Developmental Cell 18, 1041–1052, June 15, 2010 ª2010 Elsev4F; Figure S4A). Similar results were obtained using an alterna-
tive mTORC1 inhibitor, Torin 1 (Figure S4B) (Thoreen et al.,
2009). Additionally, siRNA mediated knockdown of mTOR also
failed to prevent downregulation of autophagy by any of the
cytokines (Figures S4C–S4H). Therefore, cytokines and growth
factors identified in the screen are able to regulate autophagy
via mTORC1 dependent as well as mTORC1 independent path-
ways. Additionally, only partial suppression of autophagy in the
presence of rapamycin suggests that the effects of the Akt/
mTORC1 and the cytokine-mediated mTORC1 independent
pathways on the levels of autophagy may be additive, rather
than mutually exclusive.
Growth-Promoting Pathways Negatively Regulate
Autophagy
Bioinformatics analysis of the autophagy screen hits indicated
significant enrichment for several canonical pathways known
to mediate signaling from cell surface receptors (Figure 5A; Table
S8). These pathways included the MAPK (p = 0.039), Stat3 (p =
0.008), and CXCR4 (p = 1.1 3 105) pathways regulated by the
cytokines identified in the screen. FGF2 is known to activate
the MAPK pathway. Indeed, we observed an increased level of
phospho-ERK1/2 and phospho-RSK after treatment with FGF2
(Figure 5B). Confirming the essential function of the MAPK
pathway, pretreatment with UO126, an inhibitor of MEK, attenu-
ated inhibition of autophagy after addition of FGF2 (Figure 5B).ier Inc.
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Figure 4. Cytokines Identified in the Screen
Suppress Autophagy Independently of
mTORC1 Activity
(A) Quantification of autophagy in H4 LC3-GFP
cells grown in serum-free medium supplemented
with indicated cytokines for 24 hr. All error bars
are SEM. *p < 0.05 (nR 8).
(B–F) Cytokines are able to suppress autophagy in
the absence and presence of rapamycin. H4 cells
were grown in serum-free medium, followed by
addition of 100 ng/mL IGF1 (B), 50 ng/mL FGF2
(C), 50 ng/mL LIF (D), 50 ng/mL CLCF1 (E), or
50 ng/mL SDF1 (F). Where indicated, cells were
pretreated with 50 nM rapamycin 1 hr before the
addition of cytokines. Levels of autophagy in the
presence of 10 mg/mL E64d were assessed by
western blot using antibody against LC3; mTORC1
activity was evaluated with antibodies against
phospho-S6 (Ser235/236, P-S6) and phospho-S6
kinase (Thr389, P-S6K). Quantification of LC3 II/
tubulin ratio is shown.
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(SORBS3) and tyrosine hydrolase (TH) (Table S1), are known
ERK1/2 phosphorylation targets, suggesting that they may
play a function in regulation of autophagy downstream of the
MAPK pathway. Further confirming the important function of
this pathway in the regulation of autophagy, we were able to
construct a protein-protein interaction networks anchored by
the hit genes belonging to the MAPK pathway (Figure 5C), which
encompasses 42 (18%) of all the hit genes and directly connects
to the known autophagy machinery through the interaction of the
RIP kinase 1 (RIPK1) and PKCz (PRKCZ) with p62/sequestro-
some (SQSTM1). Additionally, analysis of the promoter regions
of all the hit genes revealed significant enrichment in consensus
sites for several transcription factors (Figure 5D), including three
enriched sites for RSRFC4, a member of the serum response
factor (SRF) family, and a known downstream target of MAPK
signaling (Pollock and Treisman, 1991), suggesting additional
involvement of transcriptional regulation by the MAPK pathway
in control of autophagy under normal growth conditions.
Another hit gene pulled out of the screen as a negative regu-
lator of autophagy was the transcription factor Stat3 (Table
S1), a known mediator of LIF and CLCF1 signaling. Indeed, treat-
ment with either LIF or CLCF1 increased activating phosphoryla-Developmental Cell 18, 1041–105tion of Stat3 (Figures 5E and 5F). Consis-
tent with the essential function of Stat3,
its siRNA mediated knockdown attenu-
ated downregulation of autophagy in
response to LIF (Figure 5F). Therefore,
LIF and CLCF1 regulate autophagy
through the Stat3 pathway. Analysis of
the promoters of the core autophagy
genes uncovered the presence of a
consensus Stat3 site in the promoter of
human Atg3 gene (V$STAT3_02, p =
0.041), raising the possibility that Stat3
may also contribute to the transcrip-
tional regulation of the core autophagy
machinery.In addition to activating mTORC1, Akt is known to directly
phosphorylate and inhibit Foxo3a, a transcription factor previ-
ously shown to positively regulate autophagy during muscle
degeneration (Zhao et al., 2007). Indeed, phosphorylation of
both Akt and Foxo3a was increased after IGF-1 treatment in
both the absence and presence of rapamycin (Figure 5G;
Figure S3B; data not shown). Inhibition of Akt by treatment
with Akt inhibitor VIII attenuated phosphorylation of both Foxo3a
and the mTORC1 target S6 kinase, as well as prevented inhibi-
tion of autophagy by IGF1 (Figure 5G). Therefore, under normal
nutrient conditions IGF-1 regulates autophagy in a type I PI3
kinase/Akt dependent manner, likely through both the mTORC1
and Foxo3a pathways.
Cytokine Signaling Converges on the Type III PI3 Kinase
To further characterize the mechanism by which the cytokine
dependent signaling pathways regulate autophagy, we treated
FYVE-dsRed expressing H4 cells grown in serum-free media
with IGF1, FGF2, LIF, CLCF1, or SDF1. All of the cytokines
inhibited vesicular recruitment of FYVE-dsRed (Figure 6A; Fig-
ure S5A). Consistent with their ability to suppress autophagy in
an mTORC1 independent manner, treatment with cytokines
was able to suppress FYVE-dsRed in the presence of rapamycin2, June 15, 2010 ª2010 Elsevier Inc. 1047
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Figure 5. Growth Signaling Pathways Nega-
tively Regulate Autophagy in Response to
Cytokines
(A) Enrichment analysis of canonical pathways
(MSigDB) among the hit genes relative to all genes
examined in the screen. A p value <0.05 (hyper-
geometric distribution) is considered significant.
Only categories with at least five genes are dis-
played.
(B) Downregulation of autophagy by 50 ng/mL
FGF2 is prevented by addition of MEK inhibitor
UO126. H4 cells were grown in serum-free media,
levels of autophagy were assessed in the presence
of 10 mg/mL E64d, with antibodies against LC3,
inhibition MEK with phospho-ERK 1/2, phospho-
RSK and phospho-S6 (Ser235/236). Quantification
of LC3 II/tubulin ratio is shown.
(C) Network extensions of the canonical MAPK
pathway. Using human interactome data, this
pathway-centric network was constructed by
anchoring on canonical pathway components
and extended by establishing connections with
other hit genes, including at most one intervening
component. Red squares, screen hits that are
part of the MAPK pathway; yellow squares, other
screen hits; blue circles, intervening proteins.
(D) Enrichment analysis of cis-regulatory ele-
ments/transcription factor (TF)-binding sites in
the promoters of the hit genes, using motif-based
gene sets from MSigDB and TF-binding sites
defined in the TRANSFAC database. SRF sites
are highlighted.
(E) Phosphorylation of Stat3 after treatment with
50 ng/mL CLCF1.
(F) Downregulation of autophagy by 50 ng/mL LIF
is prevented by siRNA mediated knockdown of
Stat3. H4 cells were transfected with indicated
siRNAs for 72 hr, than cells were treated as in
(B). Protein levels and phosphorylation of Stat3
are shown.
(G) Suppression of autophagy by 100 ng/mL IGF1
is prevented by Akt inhibitor VIII. Cells were treated
as in (B). Akt activity was assessed with antibodies
against phospho-Foxo3a and phospho-rpS6.
Developmental Cell
mTORC1 Independent Regulation of Autophagy(Figure 6B). This suggests that irrespective of the upstream
signaling pathway, cytokines identified in the screen may regu-
late autophagy by modulating the levels of PtdIns3P. As treat-
ment with 3MA, an inhibitor of the type III PI3 kinase, prevented
further downregulation of PtdIns3P after treatment with cyto-
kines (Figure 6C), this is dependent on the function of the type
3 PI3 kinase rather than other cellular sources of PtdIns3P.
Confirming a crucial role of the type III PI3 kinase in regulation
of autophagy downstream of cytokine signaling, treatment with
any of the five cytokines was unable to further decrease levels
of autophagy in H4 LC3-GFP cells deficient for Beclin 1 (Fig-
ure 6D; Figure S5B), the regulatory subunit of this kinase (Shibata
et al., 2006).
In agreement with the cytokine data, knockdown of IGF1 or
CLCF1 increased vesicular accumulation of FYVE-dsRed (Table
S1). Additionally, we confirmed that inhibition of the Akt/TORC1,
MAPK, and Stat3 pathways by knockdown of their components
(mTOR, FGFR1, and Stat3/CLCF1, respectively) induced accu-1048 Developmental Cell 18, 1041–1052, June 15, 2010 ª2010 Elsevmulation of PtdIns3P as assessed by increased levels of vesic-
ular FYVE-dsRed (Figure 6E). Both, the accumulation of FYVE-
dsRed and induction of autophagy by knockdown of mTOR,
FGFR1, or CLCF1 was significantly attenuated after treatment
with 3MA (Figures 6E and 6F) and in Beclin 1 and/or Vps34
knockdown cells (Figures S5C–S5E), confirming the critical
involvement of the type III PI3 kinase in the regulation of autoph-
agy downstream of the Akt/mTOR, MAPK, and Stat3 pathways.
DISCUSSION
We developed and executed what we believe to be an innovative
high-throughput image-based screening and analysis approach,
which allowed us to identify and characterize a group of 236
genes involved in the regulation of basal levels of autophagy
under normal nutritional conditions. Further analysis showed
that the screen hits are highly enriched for genes involved in
receiving and mediating extracellular signaling. Our data showier Inc.
Figure 6. Regulation of Autophagy by Cyto-
kines Is Dependent on the Type III PI3
Kinase
(A and B) Quantification of PtdIns3P levels in H4
FYVE-dsRed cells grown in serum-free medium
supplemented for 24 hr with 100 ng/mL IGF1,
50 ng/mL FGF2, 50 ng/mL LIF, 50 ng/mL CLCF1,
or 50 ng/mL SDF1, in the absence (A) or presence
(B) of 50 nM rapamycin.
(C) Quantification of PtdIns3P levels in H4 FYVE-
dsRed cells treated with indicated cytokines in
the presence of the type III PI3 kinase inhibitor
3MA (10 mM).
(D) Quantification of levels of autophagy after cyto-
kine treatment of Beclin 1 knockdown H4 LC3-
GFP cells.
(E and F) Induction of PtdIns3P levels in H4 FYVE-
dsRed cells (E) and upregulation of autophagy in
H4 cells (F) after siRNA mediated knockdown of
indicated genes is attenuated in the presence of
3MA. Cells were transfected with indicated siR-
NAs for 72 hr, 10 mM 3MA was added for 8 hr
before cells were processed for analysis. For
western blots 10 mg/mL E64d was added and
quantification of LC3 II/tubulin ratio is shown.
**p < 0.01 (nR 6). All error bars are SEM.
(G) Model for opposing regulation of cell growth and
autophagy by the type I and type III PI3 kinases in
response to changes in extracellular environment.
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versatile manner consistent with its expanded function in the
maintenance of tissue and cell homeostasis and protection of
organisms from cancer, neurodegeneration, and other diseases.
The nutritional cues important for regulating autophagy in unicel-
lular eukaryotes have been expanded to include an extensive
array of environmental factors acting via multiple receptor-medi-
ated signaling pathways, acting in an additive manner. Unlike
starvation, the majority of these pathways are able to regulate
autophagy in mTORC1 independent manner, instead converging
on the type III PI3 kinase (see Graphical Abstract). Therefore, in
addition to playing a necessary function during execution of au-
tophagy, the type III PI3 kinase serves to integrate signals from
many pathways to allow flexible adjustment of cellular levels of
autophagy in response to diverse extracellular clues.
Interestingly, all of these pathways, including Akt/mTORC1,
Akt/Foxo3, MAPK, Stat3, and CXCR4, in addition to negatively
regulating autophagy as shown in this study, are well known to
positively regulate cell growth and proliferation. Therefore,
although autophagy is operating constantly at low levels under
physiological conditions, induction of autophagy and cell growth
may represent two alternative cell fates, which are regulated in
a mutually exclusive manner (Figure 6G). This suggests that
reducing levels of autophagy under normal nutritional condition
may be advantageous in actively proliferating cells, includingDevelopmental Cell 18, 1041–105tumors. Conversely, high levels of au-
tophagy may be incompatible with cell
growth and proliferation, and their reduc-
tion could stimulate cell proliferation.
Consistent with this hypothesis, muta-tions in at least six of the autophagy genes identified in the
screen are causally implicated in human cancers and cancer
syndromes (Table S9) (Futreal et al., 2004). We suggest that
the mutually exclusive regulation of cell growth and autophagy
is at least in part achieved through the differential activation of
the type I PI3 kinase, which is known to suppress autophagy
(Levine and Kroemer, 2008), and the type III PI3 kinase, in
response to growth factors, cytokines, and other environmental
cues. Thus, our study implicates the type III PI3 kinase as a tumor
suppressor important for the negative control of cell growth and
proliferation, providing a potential mechanism for increased
rates of cancer incidence as a result of Beclin1 deficiency (Liang
et al., 1999).
We believe our data provides important insights into the global
regulation of autophagy, provides a rich resource, and points out
novel avenues for further study of this essential cellular catabolic
pathway. Our study highlights the use of combining multilevel
screening, characterization, and bioinformatics analysis to eluci-
date global regulation of a complex biological process.EXPERIMENTAL PROCEDURES
Cell Lines and Culture Conditions
H4 human neuroblastoma cells (Krex et al., 2001) were cultured under stan-
dard TC conditions in DMEM media supplemented with 10% normal calf2, June 15, 2010 ª2010 Elsevier Inc. 1049
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mTORC1 Independent Regulation of Autophagyserum, 13 penicillin/streptomycin, and 13Na pyruvate (Invitrogen). LC3-GFP,
FYVE-dsRed, and LC3-GFP pSRP-Beclin1 knockdown H4 cells have been
described previously (Shibata et al., 2006; Zhang et al., 2007). To create
a stable line expressing Lamp1, H4 cells were transfected with Lamp1-RFP
plasmid, followed by selection with 0.4 mg/mL G418.
For the cytokine assays cells were seeded at 0.53 105 in full medium. After
24 hr, cells were transferred to serum-free medium (DMEM or OptiMEM, Invi-
trogen); growth factors were added for 6–24 hr: human LIF (GenScript Corpo-
ration, 50 ng/mL), human FGF2 (ProSpec, 50 ng/mL), human IGF1 (ProSpec,
100–200 ng/mL), human CLCF1 (R&D Systems, 50 ng/mL), or human SDF1
(ProSpec, 50–100 ng/mL). Where indicated, rapamycin or Torin 1 (a gift from
Dr. Nathaniel Gray, Harvard Medical School, Boston, MA) was added at the
same time at 50 nM. For western assays, cells were cultured overnight in
serum-free media, followed by addition of indicated cytokines and 10 mg/mL
lysosomal protease inhibitor E64d (Sigma). For signaling pathway analysis
cells were pretreated with indicated inhibitors for 1 hr before addition of cyto-
kines and E64d, or transfected with indicated siRNAs at the time of initial
plating. For CLCF1 complementation cells were transfected with indicated
siRNAs and plated in full media supplemented with 100 ng/mL human
CLCF1 and incubated for 72 hr. E64d was added for the last 6–8 hr before
cell lysis.
siRNA Transfection
For the primary screen we used an arrayed library of 21,121 siRNA pools
covering the vast majority of the human genome (Dharmacon siARRAY siRNA
library [Human Genome, G-005000-05], Thermo Fisher Scientific, Lafayette,
CO). Each pool consisted of four oligonucleotides targeting a different region
of the same gene. Each assay plate included the following controls: nontarget-
ing siRNA, mTOR, ATG5, and PLK1 (transfection efficiency control) siRNA.
siRNAs were transiently transfected in triplicate into H4 cells stably expressing
LC3-GFP reporter at 40 nM final concentration using reverse transfection.
HiPerfect reagent (QIAGEN) was diluted 1:20 in DMEM and 8 uL/well of the
mixture was aliquoted into 384-well plates using WellMate liquid handling
unit (Matrix). Two microliters of 1 uM-arrayed siRNA pools/well were added
robotically using Velocity11 Bravo. After 30 min incubation, 500 cells/well in
40 uL full media were added using WellMate. Cells were incubated for 72 hr
under standard culture conditions, counterstained with 0.5 mM Hoechst
33342 (Invitrogen) for 1 hr, and fixed with 30 uL of 8% paraformaldehyde for
30 min. Cells were washed three times with PBS using Velocity11 ELX405
Plate Washer (Bio-Tek).
For the secondary screen, we used a deconvolved library in which the four
components of each siRNA pool were separated into individual wells. The cells
were transfected and treated as for primary screen except that siRNAs were
used at 30 nM final concentration and HiPerfect was diluted 1:30 in OptiMEM
(Invitrogen). The secondary screen transfections were done in two rounds, for
a total of five replica plates, using a 1:1 mixture of LC3-GFP and FYVE-dsRed
or Lamp1-RFP cells. All tertiary characterization screens were carried out in
either triplicate or duplicate. Each assay plate included 10–12 wells of nontar-
geting siRNA as well as mTOR, ATG5, PLK1, and/or Vps34 siRNA controls. To
evaluate the contribution of inhibition of lysosomal degradation to the induc-
tion of autophagy, E64d was added at 10 mg/mL where indicated for the last
8 hr before fixation.
For follow-up assays, cells were transfected in 96-, 24-, or 6-well plates
using reverse transfection with 1–6 ml HiPerfect/mL, 10–30 nM final siRNA
concentration, and cells at 5 3 104 to 2 3 105 cells/mL, depending on the
cell type. Cells were harvested 48–72 hr after transfection.
Imaging and Image Quantification
Cells were imaged on an automated CellWoRx microscope (Applied Precision)
at 103 magnification and 350 nm (Hoechst), 488 nm (LC3-GFP), and 550 nm
(Lamp1-RFP and FYVE-dsRed) wavelengths. All images were quantified using
VHSscan and VHSview image analysis software (Cellomics). Total cell number,
total LC3-GFP intensity/cell as well as number, area, and intensity of LC3-GFP
positive autophagosomes/cell were scored. Dead and mitotic cells were
excluded from analysis based on nuclear intensity. The final autophagy score
for every well was obtained by multiplying total autophagosome intensity/cell
times number of autophagosomes/cell and dividing by average cells intensity.
This formula was empirically determined to most accurately measure LC3-1050 Developmental Cell 18, 1041–1052, June 15, 2010 ª2010 ElsevGFP translocation from cytosol into autophagosomes as reflected by consis-
tently significant Z-scores and p values when using siRNAs against mTOR and
Atg5 controls under the assay conditions and to give the highest Z0-score
(0.52, where Z0 = 1  (3SDmTOR + 3SDAtg5)/(AvemTOR  AveAtg5) (Zhang
et al., 1999). FYVE-dsRed and Lamp1-RFP scores were obtained in a similar
manner, except that in the case of Lamp1-RFP, which measures total accumu-
lation of the reporter rather than its translocation, division by the average cell
intensity was omitted.
In-Cell Western Assay
H4 cells were cultured in 384-well plates, fixed, and counterstained as
described for the LC3-GFP assay. After imaging, the cells were permeabilized
in PBS + 0.2% Tx-100 (PBST) and stained with Alexa-680 NHS-ester at
20 ng/mL for 15 min. Cells were washed with PBST and incubated for
30 min in blocking buffer (1:1 LiCOR blocking buffer/PBST) and overnight in
rabbit-anti-rpS6 phospho-235/236 (Cell Signaling Technologies) or mouse-
anti-KDEL (Stressgen) antibody at 1:1000 in blocking buffer. Cells were
washed in PBST and stained with an IRDye-800-conjugated secondary anti-
body (LiCOR) at 1:1000. The plates were scanned on the Aerius infrared
imaging system (LiCOR). The intensity of both, the rpS6 phospho-235/236 or
KDEL staining, and of NHS-ester staining were integrated, and the normalized
phospho-S6 or KDEL score was calculated for each well by dividing phospho-
rpS6 or KDEL intensity by NHS-ester intensity (Hoffman et al., 2010).
Statistical Analysis
All screen data were normalized by conversion to logarithmic scale. For
primary screen, Z-scores were calculated based on plate median (controls
excluded) and median absolute deviation, with Z-score = (cell score  median
plate score)/(plate median absolute deviation 3 1.4826) (Chung et al., 2008).
The screen hits were selected based on the median Z-score of the three
replica-plates with cut-offs set at Z-score >1.7 or <1.9 (p < 0.02). The
same method was used for the rpS6 and KDEL secondary screens except
the assays were carried out in duplicate. For LC3-GFP, FYVE-dsRed, and
Lamp1-RFP secondary screens Z-scores were calculated based on nontar-
geting siRNA control (n = 10–12) mean and standard deviation (SD). For confir-
mation of hits in the LC3-GFP assay we required that at least two of four
individual siRNA oligonucleotides for each gene had median Z-scores >1.5
or <1.5 based on five replica plates and were consistent with the primary
screen Z-score (p < 0.01). In all other secondary assays Z-scores >1.5 and
<1.5 were also considered significant. The final Z-scores for confirmed
genes were calculated based on average Z-scores of all wells for oligonucle-
otides positive in the secondary LC3-GFP assay.
The correlation analysis between LC3-GFP and other secondary assays was
carried out based on individual assay well quadrant analysis: for each well
a score of +1 was assigned if Z-scores for both features were >1.5 or
<1.5; a score of 1 if one Z-score was >1.5 while the other was <1.5;
a score of 0 if either Z-score failed to reach the cut-off. The individual well
scores were than summed up for each gene for all oligonucleotides considered
significant in the LC3-GFP secondary assay and divided by the total number of
wells assayed for these oligonucleotides. A correlation between features was
considered to be positive if the final score wasR0.5, negative if it was%0.5.
A double criteria was used for the identification of genes in which knock-
down was able to induce autophagy in the presence of E64d: (1) knockdown
of the gene in the presence of E64d was able to induce autophagy above
the levels observed with nontargeting siRNA + E64d by at least 1.5 SD, and
(2) treatment with E64d was able to increase levels of autophagy after knock-
down of the gene by at least 1.5 SD.
Relative viability was calculated by dividing number of cells in each well
based on Hoechst imaging by the average cell number in the plate. The
reported viability for each hit gene reflects average viability of all wells for oligo-
nucleotides positive in the secondary LC3-GFP assay.
Unless otherwise indicated, all remaining p values were calculated from
a two-tailed Student’s t test with equal variance. All error bars are standard
error.
Western Analysis
Cells were lysed in Laemmli sample buffer, resolved on 12% SDS-PAGE, and
transferred to PVDF membrane following standard protocols. The followingier Inc.
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mTORC1 Independent Regulation of Autophagyantibodies were used: phospho-Foxo3a and Atg5 (Sigma) at 1:500; LC3
(Novus), p62 (Pharmigen), phospho-S6K (Thr389), phospho-Akt (Ser473),
Stat3, phospho-Stat3 (Tyr705), and mTOR (all from Cell Signaling) at 1:1000;
phospho-S6 (Ser235/236) (Cell Signaling) and phospho-ERK 1/2 (Sigma) at
1:2000; tubulin (Sigma) at 1:5000. Blots were quantified using NIH ImageJ64
software.
Semiquantitative RT-PCR
Total RNA was prepared using RNeasy mini kit (QIAGEN). RNA (1.25 mg) was
used for cDNA synthesis using SuperScript First-Strand Synthesis System for
RT-PCR (Invitrogen) with oligo dT primers. Following primers were used:
FGFR1 CTCCGGCCTCTATGCTTGCGTAAC and TGCGGCTGCGGGTCACT
GTA, Stat3 ACCCCGGCTTGGCGCTGTCTCT and ACGGCTGCTGTGGGGT
GGTTGG, CLCF1 TGGGCCTGGCGGATGGGATTATTA and TGGGTCAGCC
GCAGTTTGTCATTG, b actin GACCTGACAGACTACCTCAT and AGACAGC
ACTGTGTTGGCTA.
Bioinformatics Analysis
For enrichment analyses, genes were classified into functional categories
including: biological process, molecular function (PANTHER classification
system [Mi et al., 2005]), canonical pathways (MSigDB [Subramanian et al.,
2005]), and transcription factor binding sites (MSigDB and TRANSFAC v7.4
(www.gene-regulation.com)). Genes for which no annotations could be
assigned were excluded. To assess the statistical enrichment of these cate-
gories for the hit genes relative to their representation in the global set of genes
examined, p values were computed using the hypergeometric probability
distribution. Categories with p < 0.05 were considered enriched. Similar
enrichment results were obtained independently of the details of the hit selec-
tion protocol.
Protein Interaction Network
The network was constructed by iteratively connecting interacting proteins,
with data extracted from genome-wide interactome screens (Ho et al., 2002;
Ito et al., 2001), databases: HPRD (Mishra et al., 2006), MINT (Chatr-aryamontri
et al., 2007), REACTOME (Joshi-Tope et al., 2005), and curated literature
entries implemented in the Perl programming language. The network is a graph-
ical representation of protein-protein relationships, with components (gene
products) represented as nodes and relationships (interactions) between
components as edges.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and nine tables and can be
found with this article online at doi:10.1016/j.devcel.2010.05.005.
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